Posted on May 1, 2015
Eli Lilly and Company recently announced that the FDA has approved the use of Cyramza with FOLFIRI as a second-line treatment for colorectal cancer. This treatment, previously approved for use with advanced or metastatic gastric and lung cancer, now provides metastatic colorectal cancer patients with another biologic to use in the fight against their disease.
Posted on April 30, 2015
For the past year, members of the House Energy and Commerce Committee have asked patients, doctors, researchers and regulators:
- What needs to be done to develop new treatments and cures?
- How can we get these new therapies to patients faster? Read more
Posted on April 27, 2015
We’re happy to introduce you to Antionette Rollins, the new Social Media Manger who recently joined our Colon Cancer Alliance family. Antionette has previously worked as an Online Community Specialist and Web Writer and is passionate about online communications, especially in the nonprofit sector.
Posted on April 24, 2015
We are saddened to share the loss of another friend, Randy Cox, to colon cancer. You could always count on Randy to call newly diagnosed patients to ease their worry and help them through their struggle. He represented the Colon Cancer Alliance at many outreach conferences where he bravely told his story to help prevent colon cancer. Randy was also instrumental in founding our Blue Hope Prevention Award Program with Boston Scientific, which provides qualifying individuals with financial support for the cost of screening or other screening-related expenses such as transportation, child care and lost wages.
Posted on April 23, 2015
Kyra Bishop is not your average 10 year old girl. Sure, Kyra likes to spend her time playing sports and hanging out with her brothers–but in her spare time she also likes to run 5Ks for a good cause. Earlier this month, she ran in memory of a loved one who lost their battle to colon cancer and raised over $4,800 for the us here at the Colon Cancer Alliance. We asked her to share her incredible story in her own words. Read more